1033749-83-5

Basic information

• Product Name: C₃₄H₃₆F₂N₂O₆S
• Synonyms: C₃₄H₃₆F₂N₂O₆S
• CAS NO: 1033749-83-5
• Molecular Weight: 638.732
• Mol File: 1033749-83-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: C₃₄H₃₆F₂N₂O₆S(CAS DataBase Reference)
• NIST Chemistry Reference: C₃₄H₃₆F₂N₂O₆S(1033749-83-5)
• EPA Substance Registry System: C₃₄H₃₆F₂N₂O₆S(1033749-83-5)

Safety Data

• Hazardous Substances Data: 1033749-83-5(Hazardous Substances Data)

Upstream product

• 917753-28-7 {4-[(2R,3R)-3-{[2-(4-chlorophenyl)-2-oxoethyl]thio}-1-(4-fluorophenyl)-4-oxoazetidin-2-yl]phenoxy}acetic acid 
• 13518-40-6 t-butyl D-valinate hydrochloride 
• 536-38-9 4-chlorobenzoylmethyl bromide 
• 917753-29-8 C₂₉H₂₇ClFNO₅S 
• 276884-77-6 tert-Butyl (4-formylphenoxy)acetate 
• 123-08-0 4-hydroxy-benzaldehyde 
• 858104-46-8 tert-butyl (4-{(1R)-1-[(4-fluorophenyl)amino]-2-[(4-methoxybenzyl)thio]-3-oxo-3-[(4S)-2-oxo-4-phenyl-1,3-oxazolidin-3-yl]propyl}phenoxy)acetate 
• 858104-49-1 (3R,4R)-1-(4-fluorophenyl)-3-[(4-fluorobenzoyl)methylthio]-4-[4-(t-butoxycarbonylmethoxy)phenyl]azetidin-2-one 
• 858104-48-0 (3R,4R)-1-(4-fluorophenyl)-3-[(3-nitropyridin-2-yl)dithio]-4-[4-(t-butoxycarbonylmethoxy)phenyl]azetidin-2-one 
• 858104-47-9 (3R,4R)-1-(4-fluorophenyl)-3-(4-methoxybenzylsulphanyl)-4-[4-(t-butoxycarbonylmethoxy)phenyl]azetidin-2-one 
• 858104-44-6 tert-butyl (4-{[(4-fluorophenyl)imino]methyl}phenoxy)acetate 
• 858104-50-4 (4-{(2R,3R)-1-(4-fluoro-phenyl)-3-[(RS)-2-(4-fluoro-phenyl)-2-oxoethylsulfanyl]-4-oxo-azetidin-2-yl}-phenoxy)-acetic acid 

Downstream Products

• 858104-71-9 C₃₆H₃₉F₂N₃O₇S 
• 1033696-28-4 C₃₃H₃₃F₂N₃O₈S 
• 858104-73-1 C₃₉H₄₅F₂N₃O₇S 
• 858104-72-0 C₃₉H₄₅F₂N₃O₇S 
• 1033695-21-4 C₄₁H₄₉F₂N₃O₈S 
• 858104-70-8 C₄₁H₄₉F₂N₃O₈S 
• 858104-77-5 C₄₃H₄₅F₂N₃O₈S 
• 858104-78-6 C₄₅H₅₆F₂N₄O₉S 

Relevant articles and documents

NOVEL 2-AZETIDINONE DERIVATIVES AS CHOLESTEROL ABSORPTION INHIBITORS USEFUL FOR THE TREATMENT OF HYPERLIPIDAEMIC CONDITIONS

The application relates to novel 2-azetidinone derivatives of formula (I) and pharmaceutically acceptable salts, solvates and prodrugs thereof . The compounds are cholesterol absorption inhibitors and are useful in the treatment of hyperlipidaemic conditions, including atherosclerosis, Alzheimers' disease and cholesterol associated tumours. The application also relates to pharmaceutical formulations comprising such compounds and to processes for their preparation.